Substantial intrapatient differences in the breadth and specificity of HIV-specific CD8+ T-Cell interferon-γ and proliferation responses

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 123-127

  McKinnon, Lyle R ^a   Blake Ball, T ^a,b   Wachihi, Charles ^b   Chinga, Nyakio ^b   Maingi, Anne ^b   Luo, Ma ^b   Fowke, Keith R ^b   Plummer, Francis A ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

CD8+, T cell specificity; Epitope mapping; Proliferation; Vaccine

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; EPITOPE; GAMMA INTERFERON; VIRUS ENVELOPE PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PHENOTYPE; PRIORITY JOURNAL; PROSTITUTION; VIRUS REPLICATION; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; IMMUNOLOGY; KENYA;

CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES, T-LYMPHOCYTE; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; KENYA; PROSTITUTION;

EID: 55249125414     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181869a88     Document Type: Article

References (20)

1. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8- cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68: 6103-6110.
2. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
3. Trachtenberg E, Korber B, Sollars C, et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med. 2003;9:928-935.
4. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997;3: 205-211.
5. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from, an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997;3:212-217.
6. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HiV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003;77: 2081-2092.
7. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HlV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001;75:11983-11991.
8. Zaph C, Uzonna J, Beverley SM, et al. Central memory T cells mediate long-term, immunity to Leishmania major in the absence of persistent parasites. Nat Med. 2004;10:1104-1110.
9. Alimonti JB, Koesters SA, Kimani J, et al. CD4+ T cell, responses in HIVexposed seronegative women are qualitatively distinct from, those in HIVinfected women. J Infect Dis. 2005;191:20-24.
10. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol. 2002;3:1061-1068.
11. Horton H, Frank I, Baydo R, et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV1 infection. J Immunol. 2006;177:7406-7415.
12. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107: 4781-4789.
13. Precopio ML, Betts MR, Panino J, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med. 2007;204:1405-1416.
14. Lichterfeld M, Kaufmann DE, Yu XG, et al. Loss of HIV-1 -specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccineinduced HIV-1-specific CD4+ T cells. J Exp Med. 2004;200:701-712.
15. Day CL, Kiepiela P, Leslie AJ, et al. Proliferative capacity of epitopespecific CD8 T cell responses is inversely related to viral load in chronic HIV-1 infection. J Virol. 2007;81:434-438.
16. McKinnon LR, Ball TB, Wachihi C, et al. Epitope cross-reactivity frequently differs between central and effector memory HIV-specific CD8+ T cells. J Immunol. 2007;178:3750-3756.
17. Beattie T, Kaul R, Rostron T, et al. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS. 2004;18:1595-1598.
18. Draenert R, Brander C, Yu XG, et al. Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels. AIDS. 2004;18:871-876.
19. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46-53.
20. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-763.